Dirk Timmerman Selected Research

fezolinetant

1/2021	Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.
12/2019	Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Timmerman Research Topics

Disease

21	Neoplasms (Cancer) 04/2022 - 12/2005
9	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 12/2005
6	Breast Neoplasms (Breast Cancer) 02/2011 - 09/2004
5	Ectopic Pregnancy 04/2022 - 10/2009
4	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020 - 07/2013
4	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 09/2007
3	Hemorrhage 10/2022 - 02/2006
2	Chromosomal Instability (Chromosome Stability) 04/2022 - 05/2017
2	Cysts 01/2022 - 12/2005
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021 - 04/2012
2	Insulin Resistance 01/2020 - 07/2013
2	Leiomyoma (Uterine Fibroids) 11/2015 - 04/2012
2	Testicular Neoplasms (Testicular Cancer) 07/2014 - 10/2012
2	Pain (Aches) 11/2013 - 12/2005
2	Arthralgia (Joint Pain) 07/2008 - 07/2007
2	Musculoskeletal Pain 07/2007 - 09/2004
1	Hypertension (High Blood Pressure) 10/2022
1	Carcinoma (Carcinomatosis) 04/2022
1	Endometriosis 01/2022
1	Hyperandrogenism 01/2021
1	Weight Gain 01/2020
1	Vitamin D Deficiency 01/2020
1	Overweight 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2019
1	Carcinogenesis 11/2019
1	Uterine Diseases (Endometrial Disease) 01/2019
1	Myoma 01/2017
1	Air Embolism (Gas Embolism) 01/2017
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2016
1	Hydatidiform Mole (Molar Pregnancy) 08/2016
1	Tics (Tic) 08/2016
1	Choriocarcinoma 08/2016
1	Fibroma (Fibromatosis) 03/2016
1	Adenomyosis 01/2016
1	Pneumoperitoneum 12/2013
1	Inflammation (Inflammations) 12/2013
1	Amenorrhea 11/2013
1	Birth Weight (Birth Weights) 07/2013
1	Gestational Weight Gain 07/2013
1	Obesity 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 04/2012
1	Diabetes Mellitus 04/2012
1	Sarcoma (Soft Tissue Sarcoma) 04/2012
1	Spontaneous Abortion (Miscarriage) 01/2011
1	Leiomyosarcoma 12/2009

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2009
6	Tamoxifen FDA LinkGeneric 04/2012 - 09/2004
5	Aromatase InhibitorsIBA 09/2009 - 09/2004
4	Vitamin D FDA LinkGeneric 01/2020 - 07/2013
3	Cell-Free Nucleic AcidsIBA 04/2022 - 05/2017
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2009
2	fezolinetantIBA 01/2021 - 12/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 07/2013
2	Methotrexate (Mexate)FDA LinkGeneric 08/2016 - 03/2011
1	AnticoagulantsIBA 10/2022
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	Nucleosomes (Nucleosome)IBA 04/2022
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 04/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2021
1	Carboplatin (JM8)FDA LinkGeneric 11/2021
1	InterferonsIBA 11/2021
1	CytokinesIBA 11/2021
1	Neurokinin-3 ReceptorsIBA 01/2021
1	hydroxide ionIBA 01/2020
1	activin BIBA 08/2018
1	Fibronectins (Fibronectin)IBA 08/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2016
1	Etoposide (VP 16)FDA LinkGeneric 08/2016
1	Cisplatin (Platino)FDA LinkGeneric 07/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2013
1	SolutionsIBA 12/2013
1	Levonorgestrel (Plan B)FDA LinkGeneric 11/2013
1	Anastrozole (Arimidex)FDA LinkGeneric 02/2011
1	Tumor Biomarkers (Tumor Markers)IBA 01/2010
1	Progesterone FDA LinkGeneric 12/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2009
1	ProteomeIBA 12/2009
1	Activins (Activin)IBA 10/2009
1	Inhibins (Inhibin)IBA 10/2009
1	Estrogen Receptor AntagonistsIBA 09/2009

Therapy/Procedure

6	Therapeutics 10/2022 - 05/2003
4	Hysterectomy 01/2016 - 02/2006
2	Immunotherapy 11/2021 - 11/2021
2	Adjuvant Chemotherapy 11/2021 - 09/2007
2	Morcellation 03/2016 - 11/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2016 - 12/2009
2	Drug Therapy (Chemotherapy) 07/2014 - 10/2012
1	Intrauterine Devices (Intrauterine Device) 10/2022
1	Cystectomy 01/2022
1	Gas Lasers 01/2022
1	Secondary Prevention 01/2020
1	Conservative Treatment 01/2019
1	Uterine Myomectomy 01/2017
1	Curettage 08/2016
1	Neoadjuvant Therapy 09/2014
1	Contraception (Birth Control) 11/2013
1	Salpingostomy 01/2011
1	Salpingectomy 01/2011
1	Salpingo-oophorectomy 12/2009